Urology
Volume 72, Issue 5 , Pages 1139-1143 , November 2008

Primary Scrotal Cancer: Disease Characteristics and Increasing Incidence

  • Jonathan L. Wright

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • ,
  • Todd M. Morgan

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • ,
  • Daniel W. Lin

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
    • Corresponding Author InformationReprint requests: Daniel W. Lin, M.D., Department of Urology, University of Washington Medical Center, Health Sciences Building, 1959 Northeast Pacific, BB-1115, Box 356510, Seattle, WA 98195

Received 5 March 2007 ,Accepted 7 June 2008.

References 

  1. Pott P. Cancer Scroti. In:  Hawes L,  Clarke W,  Collins R editor. Chirurgical Works. 5:London: Longman; 1775;p. 63–66
  2. Lee WR, McCann JK. Mule spinners' cancer and the wool industry. Br J Ind Med. 1967;24:148–150
  3. Dean AL. Epithelioma of scrotum. J Urol. 1948;60:508–518
  4. Graves RC, Flo S. Carcinoma of the scrotum. J Urol. 1940;43:309–332
  5. Lowe FC. Squamous-cell carcinoma of the scrotum. Urol Clin North Am. 1992;19:397–405
  6. Kickham CJE, Dufresne M. An assessment of carcinoma of the scrotum. J Urol. 1967;98:108–110
  7. Surveillance, Epidemiology and End Results (SEER) Program. In: Public-Use Data. Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2005;p. 1973–2002
  8. Parys BT, Hutton JL. Fifteen-year experience of carcinoma of the scrotum. Br J Urol. 1991;68:414–417
  9. Ray B, Whitmore WF. Experience with carcinoma of the scrotum. J Urol. 1976;117:741–745
  10. Kanitakis J. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol. 2007;21:581–590
  11. Karagas M, Greenberg E, Spencer S, et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer. 1999;81:555–559
  12. van Dam R, Huang Z, Rimm E, et al. Risk factors for basal cell carcinoma of the skin in men: Results from the health professionals follow-up study. Am J Epidemiol. 1999;150:459–468
  13. Good J, Cooper S. The Study of Medicine. In: London: Thomas and George Underwood; 1829;p. 313–315
  14. Chiu LS, Wong KH, Lam WY, et al. Angiosarcoma of the scrotum after treatment of cancer of the rectum. Clin Exp Derm. 2006;31:706–707
  15. Vapnek J, Quivey J, Carroll P. Acquired immunodeficiency syndrome-related Kaposi's sarcoma of the male genitalia: Management with radiation therapy. J Urol. 1991;146:333–336
  16. Beckenstein MS, Windle BH. Basal cell carcinoma in black patients: The need to include it in the differential diagnosis. Ann Plast Surg. 1995;35:546–548
  17. Flemming ID, Barnawell JR, Burlison PE, et al. Skin cancer in black patients. Cancer. 1975;35:600–605
  18. Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin. 1988;6:397–405
  19. Eide MJ, Weinstock MA. Association of UV index, latitude and melanoma incidence in nonwhite populations—US Surveillance, Epidemiology, and End Results (SEER) Program 1992-2001. Arch Dermatol. 2005;141:477–481
  20. Rowe DE, Carroll RJ. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976–990
  21. Rippentrop JM, Josyln SA, Badrinath RK. Squamous cell carcinoma of the penis: Evaluation of data from the Surveillance, Epidemiology, and End Results program. Cancer. 2004;101:1357–1363
  22. Demers AA, Nugent Z, Mihalcioiu C, et al. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005;53:320–328
  23. Gray DT, Suman VJ, Su WP, et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Derm. 1997;133:735–740
  24. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis. 2006;6:21–31
  25. Simms I, Fairley CK. Epidemiology of genital warts in England and Wales: 1971-1994. Sex Transmit Infect. 1997;73:365–367
  26. Pathak MA, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1002 AD. J Photochem Photobiol. 1992;14:3–22
  27. Andrews PE, Farrow GM, Oesterling JE. Squamous cell carcinoma of the scrotum: Long-term follow up of 14 patients. J Urol. 1991;146:1299–1304
  28. Guran S, Pak I. Cumulation of TP53 mutations and p16/p15 homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Cancer Genet Cytogenet. 1999;109:108–113
  29. Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation: The Photochemotherapy Follow-up Study. N Engl J Med. 1990;322:1093–1097
  30. Stern RS, Bagheri S, Nichols KT. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol. 2002;47:33–39

PII: S0090-4295(08)00836-4

doi: 10.1016/j.urology.2008.06.043

Urology
Volume 72, Issue 5 , Pages 1139-1143 , November 2008

Article Tools

* Image Usage & Resolution